302 results
Page 4 of 16
8-K
EX-99.1
3ye5na tfl
5 Aug 20
Caladrius Biosciences Announces the Resignation of Joseph Talamo, Chief Financial Officer
4:07pm
8-K
EX-99.1
3222vse3v
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
424B3
06dtnak754jicjsc30y
29 Jun 20
Prospectus supplement
12:00am
424B5
fkwcwr a7gmj
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-99.1
re4ubi
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-99.1
asfqe5vvq0rqhl
7 May 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results
4:09pm
424B5
0sehkzyc
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-99.2
prp0fzghql1
5 Mar 20
Caladrius Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:07pm
8-K
EX-99.2
6wv2zw
18 Nov 19
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019
6:21am
424B5
q1289e
20 Mar 19
Prospectus supplement for primary offering
5:19pm
424B5
9lj y8vn7ocdz
14 Mar 19
Prospectus supplement for primary offering
4:23pm